Mannatech Net Current Debt 2010-2025 | MTEX

Mannatech net current debt from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.

Mannatech Net Current Debt 2010-2025 | MTEX

Mannatech net current debt from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$77B
Zoetis (ZTS)$70.7B
Takeda Pharmaceutical (TAK)$47.2B
Daiichi Sankyo, - (DSNKY)$41.5B
BeOne Medicines - (ONC)$27.8B
Sandoz Group AG (SDZNY)$24.6B
Summit Therapeutics (SMMT)$19.2B
Merck (MKKGY)$17.3B
Shionogi (SGIOY)$14.3B
United Therapeutics (UTHR)$13.5B
Neurocrine Biosciences (NBIX)$13.4B
Orion OYJ (ORINY)$11.1B
IPSEN (IPSEY)$10.3B
Stevanato Group S.p.A (STVN)$7.9B
Corcept Therapeutics (CORT)$7.6B
Madrigal Pharmaceuticals (MDGL)$7B
Ionis Pharmaceuticals (IONS)$6.7B
Grifols, S.A (GRFS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$4B
Hypermarcas (HYPMY)$3.2B
Crinetics Pharmaceuticals (CRNX)$3B
Catalyst Pharmaceuticals (CPRX)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.5B
Centessa Pharmaceuticals (CNTA)$2B
BioCryst Pharmaceuticals (BCRX)$1.9B
ARS Pharmaceuticals (SPRY)$1.8B
Ocular Therapeutix (OCUL)$1.8B